Parkman Healthcare Partners’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-559,755
| Closed | -$6.55M | – | 91 |
|
|
2022
Q2 | $6.55M | Buy |
559,755
+250,169
| +81% | +$2.93M | 2.41% | 13 |
|
|
2022
Q1 | $1.89M | Buy |
309,586
+46,112
| +18% | +$281K | 0.55% | 49 |
|
|
2021
Q4 | $2.41M | Buy |
263,474
+88,474
| +51% | +$810K | 0.53% | 51 |
|
|
2021
Q3 | $1.98M | Sell |
175,000
-25,000
| -13% | -$283K | 0.5% | 54 |
|
|
2021
Q2 | $1.97M | Buy |
+200,000
| New | +$1.97M | 0.43% | 58 |
|
|
2021
Q1 | – | Sell |
-100,000
| Closed | -$1.13M | – | 84 |
|
|
2020
Q4 | $1.13M | Buy |
+100,000
| New | +$1.13M | 0.29% | 74 |
|